Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III long-term study of TY-0201 (bisoprolol patch) in chronic atrial fibrillation
jRCT2080222649Phase 3Completed
- Sponsor
- TOA EIYO
- Start
- Nov 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of bisoprolol in Atrial fibrillation (AFib) (4 arms), sponsored by TOA EIYO. Started Nov 2014; status: completed.
02
Drugs
bisoprolol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on jRCT2080222649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222649.